SteveYoon-HoChoMD

Nuclear Medicine • Madison, WI

Section Chief, Nuclear Medicine and Molecular Imaging Section, Professor of Radiology, University of Wisconsin School of Medicine and Public Health

Join to view full profile

Dr. Cho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cho's full profile

Already have an account?

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-263-8340

Fax+1 608-263-0682

Summary

Director of Radiopharmaceutical Production Facility,
Director of Cancer Research Imaging Core, UW Carbone Cancer Center,
Program Director, Nuclear Medicine Residency,
Associate Director of UW PET Imaging Center

Education & Training

Johns Hopkins University School of MedicineFellowship, PET/CT Fellowship, 2006 - 2007
Johns Hopkins UniversityResidency, Nuclear Medicine, 2004 - 2006
NIH Clinical CenterFellowship, Clinical Pharmacology Research Fellowship (ClinPRAT), 2001 - 2004
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Johns Hopkins UniversityResidency, Pediatrics, 1995 - 1998
New York University School of MedicineClass of 1995, MD, Research Honors
Johns Hopkins UniversityBA, Biology, 1987 - 1991

Certifications & Licensure

WI State Medical License 2014 - 2025
MD State Medical License 2001 - 2016
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer Start of enrollment: 2011 May 01
Completed
Phase 1
Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer Start of enrollment: 2010 Sep 01
Completed
Phase 1
Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer Start of enrollment: 2012 Sep 11
Completed
Phase 1, Phase 2
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy Start of enrollment: 2012 Apr 16
Completed
Early Phase 1
Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer Start of enrollment: 2013 Mar 01
Completed
Phase 1, Phase 2
Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer Start of enrollment: 2014 May 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network.
Xin Tie, Muheon Shin, Changhee Lee, Scott B Perlman, Zachary Huemann
Radiology. Artificial Intelligence. 2025-02-19
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy.
Victor Santoro-Fernandes, Brayden Schott, Amy J Weisman, Ojaswita Lokre, Steve Y Cho
Journal of Nuclear Medicine. 2025-02-13
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on ...
Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, Lars Kurch, Kathleen M McCarten
Radiology. 2025-01-01

Press Mentions

The Age of Melanoma EnlightenmentAugust 16th, 2018
Cai Research Group at the 2017 SNMMI Annual Meeting in DenverJune 20th, 2017
RSNA Grant Recipients Develop Licensed PET RadiotracerMay 26th, 2016
Join now to see all